Reopening America

Eli Lilly Given Emergency Use Authorization for COVID Treatment

The FDA this week gave the emergency use authorization to Eli Lilly for their monoclonal antibody Covid treatment. It is similar to the treatment that President Trump received when he was sick and is aimed at keeping mild cases from turning more serious. The process of getting this treatment developed and approved was difficult in that the company also had to deal with the pandemic at the same time. They had to trim down their staff, work remotely in some cases, and the chief of the lab had to use a robot with an iPad attached to it so he can patrol the lab. Peter Loftus, health care reporter at the WSJ, joins us for how Eli Lilly got it done. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.